Data for (Study ST000663)

(Analysis AN001012)

Values for each metabolite have been scaled by dividing by the mean across all factors

Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study

MetaboliteF1F2F3F4
Arachidonic acid 0.7546 0.9676 1.2052 1.0726
CerP 32:1; [M-H]-@5.15 0.9346 0.8383 1.4314 0.7956
CerP 34:1; [M-H]-@5.86 1.1001 0.7276 1.1320 1.0404
CL 70:1; [M-2H](2-)@6.86 1.2098 0.8061 1.1874 0.7967
CL 70:5; [M-2H](2-)@6.08 1.0388 1.0003 1.2084 0.7525
CL 74:1; [M-2H](2-)@7.42 0.9815 1.0044 1.3552 0.6590
CL 74:3; [M-2H](2-)@6.97 1.1283 0.9676 1.0584 0.8457
CL 74:5; [M-2H](2-)@6.61 1.1505 0.8130 1.2915 0.7451
CL 74:7; [M-2H](2-)@6.10 1.0352 0.8676 1.3114 0.7858
CL 78:5; [M-2H](2-)@7.25 0.9233 1.0100 1.0642 1.0026
CL 78:7; [M-2H](2-)@6.72 0.9358 0.9830 1.2592 0.8220
CL 78:9; [M-2H](2-)@6.53 1.0130 0.9096 1.2549 0.8225
CL 82:13; [M-2H](2-)@6.39 0.9636 0.6725 1.5090 0.8549
CL 82:9; [M-2H](2-)@7.10 0.8615 0.8674 1.2815 0.9896
FFA(16:0) 0.9367 0.9418 1.1053 1.0162
FFA(18:0) 0.9952 0.9342 1.1004 0.9703
FFA(18:1) 0.7705 1.0178 1.1440 1.0677
FFA(18:2) 0.7746 0.9931 1.1417 1.0906
FFA(20:0) 1.0812 0.9177 1.0546 0.9465
FFA(20:1) 0.7919 1.0283 1.1760 1.0039
FFA(20:2) 0.7075 0.9943 1.2070 1.0912
FFA(22:0) 1.1326 0.8824 1.0290 0.9560
FFA(22:1) 1.2486 0.8408 1.1387 0.7720
FFA(22:2) 0.8280 0.9817 1.2684 0.9218
FFA(22:3) 0.7403 1.0547 1.2160 0.9889
FFA(24:0) 1.2380 0.8895 1.0094 0.8631
FFA(24:1) 1.0748 0.8147 1.2160 0.8945
FFA(24:2) 0.9411 0.8373 1.3315 0.8901
FFA(24:3) 0.9816 0.7692 1.5258 0.7233
lysoPE 16:0; [M-H]-@1.70 1.2979 0.7633 1.0309 0.9079
lysoPE 18:0; [M-H]-@2.45 1.0694 0.9164 1.1104 0.9037
lysoPE 18:1; [M-H]-@1.87 1.1425 0.8787 1.1652 0.8137
lysoPE 18:2; [M-H]-@1.40 1.1832 0.8864 1.0482 0.8822
lysoPE 20:3; [M-H]-@1.66 1.0294 0.9600 1.0232 0.9874
lysoPE 20:4; [M-H]-@1.38 0.8696 0.9742 1.1238 1.0324
lysoPE 22:4; [M-H]-@1.92 0.8224 1.1529 1.3403 0.6843
lysoPE 22:5; [M-H]-@1.56 0.8620 1.0606 1.0959 0.9815
lysoPE 22:6; [M-H]-@1.33 0.8752 0.8044 1.2781 1.0423
MGDG 22:1; [M-H]-@1.48 0.9970 0.9355 1.1295 0.9380
PA 34:0; [M-H]-@5.19 0.8314 0.8128 1.4005 0.9552
PA 34:0; [M-H]-@6.91 1.2035 0.7115 1.1605 0.9246
PA 34:0; [M-H]-@7.49 0.8989 0.9444 1.2005 0.9562
PA 38:6; [M-H]-@6.11 0.9268 1.1189 0.9238 1.0304
PC 28:0; [M-Ac-H]-@5.23 1.3322 0.7132 1.2425 0.7121
PC 29:0; [M-Ac-H]-@5.57 1.5191 0.7635 0.9731 0.7443
PC 30:0; [M-Ac-H]-@5.96 1.2695 0.8135 1.2376 0.6793
PC 30:1; [M-Ac-H]-@5.40 1.0525 1.0026 1.3050 0.6399
PC 30:2; [M-Ac-H]-@4.91 0.7313 1.0201 1.3443 0.9043
PC 31:0; [M-Ac-H]-@6.26 1.1196 0.9843 0.7402 1.1560
PC 31:1; [M-Ac-H]-@5.76 0.9829 1.1781 1.0527 0.7863
PC 32:0; [M-Ac-H]-@6.58 1.0656 0.8940 1.1723 0.8681
PC 32:1; [M-Ac-H]-@6.08 1.0003 1.0672 1.0927 0.8398
PC 32:2; [M-Ac-H]-@5.59 1.0691 0.9068 1.1848 0.8393
PC 32:3; [M-Ac-H]-@5.15 1.1895 0.8464 1.2914 0.6727
PC 33:0; [M-Ac-H]-@6.79 1.0576 1.2230 0.9287 0.7907
PC 33:1; [M-Ac-H]-@6.42 0.9849 0.9787 1.1190 0.9174
PC 33:2; [M-Ac-H]-@5.96 1.0257 0.9572 1.0724 0.9446
PC 34:0; [M-Ac-H]-@7.16 1.0060 0.9913 1.0044 0.9982
PC 34:1; [M-Ac-H]-@6.62 1.0726 0.9175 1.2036 0.8063
PC 34:1; [M-Ac-H]-@6.69 1.0726 0.9175 1.2036 0.8063
PC 34:2; [M-Ac-H]-@6.21 1.0984 0.9484 1.0927 0.8605
PC 34:3; [M-Ac-H]-@5.76 0.9981 0.9272 1.1715 0.9032
PC 34:4; [M-Ac-H]-@5.55 0.9335 0.9644 1.1835 0.9187
PC 34:5; [M-Ac-H]-@5.14 0.8765 1.2325 1.1446 0.7464
PC 35:1; [M-Ac-H]-@6.99 1.1695 0.9648 0.9727 0.8930
PC 35:2; [M-Ac-H]-@6.54 1.0610 0.9506 1.1129 0.8755
PC 35:3; [M-Ac-H]-@6.11 1.0847 0.9723 0.9298 1.0132
PC 35:4; [M-Ac-H]-@5.93 0.8800 0.9599 1.2504 0.9097
PC 35:5; [M-Ac-H]-@5.49 0.7570 0.8499 1.5714 0.8217
PC 36:1; [M-Ac-H]-@7.26 1.0703 0.9356 1.1091 0.8851
PC 36:2; [M-Ac-H]-@6.82 1.1125 0.9007 1.0926 0.8942
PC 36:3; [M-Ac-H]-@6.40 1.0025 0.9435 1.1263 0.9278
PC 36:4; [M-Ac-H]-@6.08 0.8590 0.9116 1.2480 0.9814
PC 36:5; [M-Ac-H]-@5.66 0.8932 0.8584 1.3335 0.9149
PC 36:6; [M-Ac-H]-@5.45 1.0527 0.8005 1.1995 0.9472
PC 37:2; [M-Ac-H]-@7.17 1.2782 0.8338 0.9928 0.8951
PC 37:3; [M-Ac-H]-@6.73 0.9223 0.8905 1.2808 0.9064
PC 37:4; [M-Ac-H]-@6.52 0.8378 0.9084 1.2727 0.9811
PC 37:5; [M-Ac-H]-@6.03 0.8338 0.8921 1.2458 1.0283
PC 37:6; [M-Ac-H]-@5.82 1.0868 0.8235 1.0311 1.0585
PC 38:2; [M-Ac-H]-@7.43 1.0955 0.9374 1.0310 0.9361
PC 38:3; [M-Ac-H]-@7.06 0.9075 0.9914 1.1498 0.9513
PC 38:4; [M-Ac-H]-@6.75 0.8329 0.8909 1.2537 1.0225
PC 38:5; [M-Ac-H]-@6.33 0.8558 0.9185 1.2487 0.9770
PC 38:5; [M-Ac-H]-@6.55 0.8558 0.9185 1.2487 0.9770
PC 38:6; [M-Ac-H]-@6.01 1.0210 0.8022 1.2232 0.9536
PC 38:7; [M-Ac-H]-@5.54 1.0607 0.8333 1.2162 0.8898
PC 39:4; [M-Ac-H]-@7.09 0.9934 0.9344 1.2899 0.7824
PC 39:5; [M-Ac-H]-@6.62 0.7551 0.9992 1.3232 0.9224
PC 39:6; [M-Ac-H]-@6.40 1.0139 0.8844 1.2495 0.8523
PC 40:3; [M-Ac-H]-@7.61 1.1079 0.9439 1.1257 0.8224
PC 40:4; [M-Ac-H]-@7.30 0.9510 1.0312 1.1349 0.8828
PC 40:5; [M-Ac-H]-@7.04 0.9087 0.9254 1.2035 0.9624
PC 40:6; [M-Ac-H]-@6.72 0.8084 0.9393 1.3661 0.8862
PC 40:7; [M-Ac-H]-@6.25 0.9678 0.7938 1.2450 0.9934
PC 40:8; [M-Ac-H]-@5.79 1.0516 0.8761 1.2525 0.8198
PC 42:10; [M-Ac-H]-@5.73 0.8122 0.9801 1.2399 0.9678
PC 42:2; [M-Ac-H]-@8.50 1.2515 0.9391 0.8961 0.9133
PC 42:4; [M-Ac-H]-@7.97 1.1984 1.0541 0.9396 0.8079
PC 44:4; [M-Ac-H]-@8.45 1.3235 0.9003 1.0088 0.7674
PE 32:1; [M-H]-@6.27 1.1534 1.0123 1.1176 0.7167
PE 33:2; [M-H]-@6.10 0.9756 1.0100 0.9873 1.0271
PE 34:0; [M-H]-@7.27 1.0053 0.9982 1.0007 0.9958
PE 34:1; [M-H]-@6.86 1.1586 0.8916 1.1935 0.7562
PE 34:2; [M-H]-@5.10 1.0572 0.9887 0.9865 0.9676
PE 34:2; [M-H]-@6.43 1.0830 0.8926 1.1920 0.8323
PE 34:3; [M-H]-@6.07 0.9989 1.0891 1.1079 0.8041
PE 35:1; [M-H]-@7.13 1.0908 1.1680 0.9466 0.7946
PE 35:2; [M-H]-@6.72 1.1651 0.9510 0.9384 0.9456
PE 35:4; [M-H]-@6.08 1.1450 1.1435 0.9138 0.7978
PE 36:0; [M-H]-@7.84 0.9449 0.9556 1.0267 1.0728
PE 36:1; [M-H]-@6.69 0.8987 1.0705 1.2231 0.8077
PE 36:1; [M-H]-@7.44 0.9247 1.0838 1.2530 0.7386
PE 36:2; [M-H]-@5.72 1.0007 1.1426 1.0723 0.7844
PE 36:3; [M-H]-@5.24 1.0292 1.1849 1.0251 0.7609
PE 36:3; [M-H]-@6.56 1.1090 0.8663 1.2609 0.7637
PE 36:4; [M-H]-@6.26 1.0347 0.9475 1.2017 0.8161
PE 36:5; [M-H]-@6.04 0.9332 0.8934 1.2683 0.9051
PE 37:4; [M-H]-@6.70 0.8717 0.9663 1.3447 0.8173
PE 38:1; [M-H]-@7.88 0.8379 1.0173 1.1190 1.0258
PE 38:2; [M-H]-@7.58 1.0314 1.2115 1.1326 0.6246
PE 38:3; [M-H]-@7.25 0.8828 1.0431 1.0394 1.0347
PE 38:4; [M-H]-@6.97 0.9268 1.0220 1.0702 0.9811
PE 38:5; [M-H]-@6.55 0.9719 0.9139 1.2796 0.8346
PE 38:6; [M-H]-@6.18 1.0422 0.8045 1.1729 0.9804
PE 40:4; [M-H]-@7.44 0.9180 1.2196 1.0834 0.7790
PE 40:5; [M-H]-@7.11 0.8541 0.9324 1.1107 1.1028
PE 40:6; [M-H]-@6.92 0.9253 0.6652 1.3455 1.0640
PE 40:7; [M-H]-@6.41 0.9984 0.7690 1.3449 0.8877
PG 34:0; [M-H]-@6.40 1.0000 1.0000 1.0000 1.0000
PG 34:2; [M-H]-@5.57 1.1610 1.0345 0.9824 0.8221
PG 36:2; [M-H]-@6.15 0.8100 1.2872 0.9257 0.9771
PG 36:3; [M-H]-@5.43 1.0215 0.9631 1.2102 0.8051
PG 38:4; [M-H]-@6.14 0.8267 1.1040 1.1053 0.9640
PI 34:1; [M-H]-@5.77 1.2224 1.0286 1.0120 0.7370
PI 34:2; [M-H]-@5.37 1.1357 1.0101 0.9696 0.8845
PI 36:1; [M-H]-@6.40 1.1819 0.9619 1.1317 0.7245
PI 36:2; [M-H]-@6.01 1.2316 1.0354 1.0100 0.7229
PI 37:4; [M-H]-@5.66 1.0025 1.0027 0.9980 0.9968
PI 38:3; [M-H]-@6.20 0.9834 1.1519 0.8604 1.0043
PI 38:4; [M-H]-@5.99 1.0074 0.9182 1.1234 0.9510
PI 38:5; [M-H]-@5.48 1.1826 0.9294 0.9502 0.9378
PI 38:6; [M-H]-@5.24 1.3739 0.7325 1.1390 0.7546
PI 40:5; [M-H]-@6.08 0.9068 0.9896 1.3243 0.7793
plasmenyl-PE 32:1; [M-H]-@6.62 0.6529 1.0454 1.3204 0.9814
plasmenyl-PE 34:0; [M-H]-@7.24 1.0248 0.9648 1.1126 0.8978
plasmenyl-PE 34:1; [M-H]-@7.19 0.7570 0.9949 1.1413 1.1068
plasmenyl-PE 34:2; [M-H]-@6.75 0.9148 1.2035 0.9827 0.8990
plasmenyl-PE 34:3; [M-H]-@6.34 0.8858 1.2886 0.8850 0.9406
plasmenyl-PE 36:1; [M-H]-@7.73 0.9318 1.0417 1.0162 1.0104
plasmenyl-PE 36:2; [M-H]-@7.35 1.0737 0.9803 0.9820 0.9640
plasmenyl-PE 36:3; [M-H]-@6.90 1.0236 0.9458 1.0639 0.9667
plasmenyl-PE 36:4; [M-H]-@6.67 0.7518 1.0922 1.2801 0.8759
plasmenyl-PE 36:5; [M-H]-@6.35 0.9622 0.9183 1.3120 0.8075
plasmenyl-PE 38:1; [M-H]-@8.22 1.2367 0.9322 1.0676 0.7634
plasmenyl-PE 38:2; [M-H]-@7.88 1.0733 1.0529 0.9422 0.9316
plasmenyl-PE 38:3; [M-H]-@7.48 1.0358 0.9894 1.0178 0.9570
plasmenyl-PE 38:4; [M-H]-@7.24 0.8720 1.1920 0.9734 0.9626
plasmenyl-PE 38:4; [M-H]-@7.37 0.8720 1.1920 0.9734 0.9626
plasmenyl-PE 38:5; [M-H]-@6.78 0.9219 0.9606 1.2253 0.8922
plasmenyl-PE 38:6; [M-H]-@6.57 0.9010 0.8483 1.3383 0.9124
plasmenyl-PE 40:3; [M-H]-@8.07 0.9473 1.0373 1.0959 0.9196
plasmenyl-PE 40:4; [M-H]-@7.77 0.9173 1.3186 0.9562 0.8079
plasmenyl-PE 40:5; [M-H]-@7.34 1.0013 0.9964 1.0731 0.9293
plasmenyl-PE 40:5; [M-H]-@7.45 1.0013 0.9964 1.0731 0.9293
plasmenyl-PE 40:6; [M-H]-@7.21 1.0380 0.8465 1.1052 1.0103
plasmenyl-PE 42:4; [M-H]-@8.19 1.0933 1.0223 1.1444 0.7399
plasmenyl-PE 42:5; [M-H]-@7.88 1.0124 0.9998 1.1107 0.8771
plasmenyl-PE 42:6; [M-H]-@7.77 1.3076 0.7728 1.1203 0.7992
PS 34:0; [M-H]-@6.36 1.0225 0.9776 0.9971 1.0028
PS 36:1; [M-H]-@6.48 1.1161 1.2867 0.9835 0.6137
PS 38:4; [M-H]-@6.08 1.1081 1.7479 0.5881 0.5558
PS 38:5; [M-H]-@5.64 0.9905 1.4180 0.8294 0.7621
Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study

Factors:

F1control:Control | visit:Control
F2control:Metabolic syndrom | visit:MS Visit 1
F3control:Metabolic syndrom | visit:MS Visit 3
F4control:Metabolic syndrom | visit:MS Visit 4
  logo